The latest closing stock price for Esperion Therapeutics as of January 31, 2025 is 1.79.
An investor who bought $1,000 worth of Esperion Therapeutics stock at the IPO in 2013 would have $-877 today, roughly -1 times their original investment - a -16.00% compound annual growth rate over 12 years.
The all-time high Esperion Therapeutics stock closing price was 115.30 on May 19, 2015.
The Esperion Therapeutics 52-week high stock price is 3.94, which is 120.1% above the current share price.
The Esperion Therapeutics 52-week low stock price is 1.58, which is 11.7% below the current share price.
The average Esperion Therapeutics stock price for the last 52 weeks is 2.26.
An investor who bought $1,000 worth of Esperion Therapeutics stock at the IPO in 2013 would have $-877 today, roughly -1 times their original investment - a -16.00% compound annual growth rate over 12 years.
The all-time high Esperion Therapeutics stock closing price was 115.30 on May 19, 2015.
The Esperion Therapeutics 52-week high stock price is 3.94, which is 120.1% above the current share price.
The Esperion Therapeutics 52-week low stock price is 1.58, which is 11.7% below the current share price.
The average Esperion Therapeutics stock price for the last 52 weeks is 2.26.